NSETrading Window26 Jun 2026 · 26 Jun 2026, 01:11 pm
Trading Window
BALAXI PHARMACEUTICALS LIMITED · BALAXI
✦ AI Summary
Balaxi Pharmaceuticals Limited has informed the Exchange regarding the closure of the trading window for insiders due to the upcoming declaration of unaudited financial results for the quarter ending 30th June, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
BALAXI_26062026131048_Intimation_of_Closure_of_Trading_Window_26062026.pdf
View document text
Date: 26th June, 2026
Listing Department,
National Stock Exchange of India Limited
Exchange Plaza, Plot No C-1, Block G, Bandra Kurla Complex,
Bandra (E), Mumbai – 400051
Ref: NSE Symbol: BALAXI
Dear Sir/Madam,
Sub: Intimation of Closure of Trading Window
Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading)
Regulations, 2015 and the Company’s Code of Internal Procedures and Conduct to regulate,
monitor and report trading by Insiders, the trading window for dealing in securities of the
Company for all the Designated Persons and their Immediate Relatives will remain closed
from July 01, 2026 till conclusion of 48 hours after the declaration of Unaudited Financial
Results of the Company for the quarter ending 30th June, 2026.
The date of the meeting of Board of Directors for the consideration and approval of the
Unaudited Financial Results of the Company for the quarter ending 30th June, 2026 will be
informed in due course.
This is for your information and records.
Thanking You.
For Balaxi Pharmaceuticals Limited
Aman Purohit
(Company Secretary & Compliance Officer)
ICSI Membership No.: A59345